HSG 2018 poster: Partial lowering of total huntingtin levels to treat adults with Huntington’s disease (HD): potential benefits and theoretical risks from human studies and animal models

Nov 08, 2018 by [Blair R Leavitt, Scott A Schobel, Holly Kordasiewicz]

This poster presents a review of published clinical and preclinical studies on the effect of lowering wtHTT.

Current View

Receive this presentation and more content via email